Inactive Instrument
Vivesto AB Share Price OTC Markets
Stocks
OASMY
US67421W1099
Pharmaceuticals
OTC Markets Traded| Market Cap | 80.27M 7.87M 7.17M 6.64M 6.01M 11.27M 735M 11.79M 31.84M 397M 29.54M 28.92M 1.26B | P/E 2026 * |
-2.59x | P/E 2027 * | -2.06x |
|---|---|---|---|---|---|
| Enterprise Value | 69.27M 6.79M 6.19M 5.73M 5.18M 9.72M 635M 10.18M 27.48M 343M 25.49M 24.96M 1.09B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
52.67% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Vivesto AB
| Manager | Title | Age | Since |
|---|---|---|---|
Erik Kinnman
CEO | Chief Executive Officer | 68 | 22/01/2023 |
Björn Svanström
DFI | Director of Finance/CFO | 55 | 30/06/2026 |
| Chief Tech/Sci/R&D Officer | 39 | 31/12/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 46 | 24/05/2022 | |
Hege Hellstrom
BRD | Director/Board Member | 61 | 25/09/2019 |
Pål Ryfors
BRD | Director/Board Member | 43 | 24/05/2022 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -99.00% | - | - | 7.87M | ||
| -2.29% | -5.34% | +28.73% | +128.34% | 1,204B | ||
| -2.04% | -5.78% | +31.91% | +78.34% | 643B | ||
| -0.86% | -3.71% | +21.74% | +105.02% | 501B | ||
| -0.01% | -1.09% | +28.38% | +68.80% | 378B | ||
| -3.61% | -9.62% | +39.73% | +30.53% | 327B | ||
| +0.58% | -4.42% | +27.60% | +52.04% | 285B | ||
| +1.20% | -3.83% | -1.49% | +33.05% | 270B | ||
| -1.14% | -6.05% | +28.16% | +65.35% | 237B | ||
| -1.45% | -0.85% | +30.03% | +120.72% | 207B | ||
| Average | -0.96% | -4.40% | +26.09% | +75.80% | 450B | |
| Weighted average by Cap. | -1.42% | -4.71% | +27.16% | +88.26% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -28M -2.75M -2.5M -2.32M -2.1M -3.93M -257M -4.11M -11.11M -139M -10.3M -10.09M -439M | -39M -3.83M -3.49M -3.23M -2.92M -5.47M -357M -5.73M -15.47M -193M -14.35M -14.05M -612M |
| Net Debt | -11M -1.08M -983K -910K -823K -1.54M -101M -1.62M -4.36M -54.45M -4.05M -3.96M -172M | -20M -1.96M -1.79M -1.65M -1.5M -2.81M -183M -2.94M -7.93M -99.01M -7.36M -7.21M -314M |
Employees
4
Sector
Pharmaceuticals
















